Document is current
Any future updates will be listed below
-
Authors
Nieder, Carsten
Aanes, Siv Gyda
Stanisavljevic, Luka
Mannsåker, Bård
Haukland, Ellinor Christin
-
Funding
Funding for this research was provided by:
UiT The Arctic University of Norway
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 24 September 2024
First Online: 1 October 2024
Declarations
:
: S.G.A. has received lecture fees from Merck, BMS, Astra Zeneca and Pfizer. B.M. has received lecture fees from BMS, Astra Zeneca, Gilead, Roche, Novartis and Pfizer. L.S. has received lecture fees from Pfizer, MSD, Janssen and Ipsen. L.S. har received consulting fees from MSD. Other authors: no conflict of interests.
: This is an observational study. The REK Nord Research Ethics Committee has confirmed that no ethical approval is required.
